AbCellera Announces Positive Phase 2 Results for Vasomotor Symptom Therapy

AbCellera reported "striking" positive outcomes from its Phase 2 clinical trial for a vasomotor symptoms treatment. These results surpassed expectations, indicating a potential significant advancement in developing new therapies for these symptoms. This success could lead to further development and eventually offer a new option for patients.